Market Cap 267.65M
Revenue (ttm) 0.00
Net Income (ttm) -148.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 2,691,700
Avg Vol 5,213,926
Day's Range N/A - N/A
Shares Out 158.37M
Stochastic %K 35%
Beta 1.89
Analysts Strong Sell
Price Target $8.29

Company Profile

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It...

Industry: Biotechnology
Sector: Healthcare
Phone: 919 313 9633
Address:
2525 East North Carolina Highway 54, Durham, United States
Bob584
Bob584 Oct. 24 at 8:20 PM
$HUMA All my 24,495 shares were out on loan to shorts and all have come back in this week. Obviously, I need to buy 5 more shares on Monday to even things out before this takes off. Institutions have been loading up, I might as well top mine off.
1 · Reply
Ppbrain
Ppbrain Oct. 24 at 8:01 PM
$HUMA The CEO and her husband after scamming investors out of their pockets....
0 · Reply
billyl
billyl Oct. 24 at 5:57 PM
$HUMA agreed… will melt up to 7-8 easily after few more Qs of gang buster sales… docs are often timid and operated in herb mentality… But Military trends setting usages; once they proven working in military which they have already in Ukraine… ka Ching!! Recent 2ndary IPO provides runway capital to enable adequate inventory supply support
0 · Reply
billyl
billyl Oct. 24 at 5:48 PM
$HUMA wars and crazy street violences are never going to stop… and seem only increasing… HUMA’s new tech will treat soldiers and trauma patients with faster recovery and less complications - ER will be good to great…!!!
0 · Reply
FatherofTrades
FatherofTrades Oct. 24 at 5:46 PM
$HUMA 2C January 26, 3C Jan 27.
1 · Reply
jmlin1
jmlin1 Oct. 24 at 5:27 PM
$HUMA what is poor thing that can not make a move even in this market.
0 · Reply
Diefreeandsell
Diefreeandsell Oct. 24 at 1:12 PM
$HUMA looks good to me, you?
1 · Reply
Ppbrain
Ppbrain Oct. 24 at 6:54 AM
$HUMA this is how the CEO and her husband sleep every night, knowing they rugged investor hard earn cash...
1 · Reply
Diefreeandsell
Diefreeandsell Oct. 23 at 6:02 PM
$HUMA 50% more please!
0 · Reply
stocktwitsaccount69
stocktwitsaccount69 Oct. 23 at 3:53 PM
$HUMA Nov $2 calls look dirt cheap
0 · Reply
Latest News on HUMA
Humacyte: Cash Burn And A Glacial Launch Overshadow VAC Progress

Aug 12, 2025, 1:20 PM EDT - 2 months ago

Humacyte: Cash Burn And A Glacial Launch Overshadow VAC Progress


Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 10:00 AM EDT - 2 months ago

Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript


Humacyte: Revenue Ramp From Symvess Incoming

Jun 11, 2025, 9:05 AM EDT - 4 months ago

Humacyte: Revenue Ramp From Symvess Incoming


Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript

May 13, 2025, 2:29 PM EDT - 5 months ago

Humacyte, Inc. (HUMA) Q1 2025 Earnings Call Transcript


Trestle Bio Announces Research Collaboration with Humacyte

Mar 6, 2025, 8:00 AM EST - 8 months ago

Trestle Bio Announces Research Collaboration with Humacyte


Bob584
Bob584 Oct. 24 at 8:20 PM
$HUMA All my 24,495 shares were out on loan to shorts and all have come back in this week. Obviously, I need to buy 5 more shares on Monday to even things out before this takes off. Institutions have been loading up, I might as well top mine off.
1 · Reply
Ppbrain
Ppbrain Oct. 24 at 8:01 PM
$HUMA The CEO and her husband after scamming investors out of their pockets....
0 · Reply
billyl
billyl Oct. 24 at 5:57 PM
$HUMA agreed… will melt up to 7-8 easily after few more Qs of gang buster sales… docs are often timid and operated in herb mentality… But Military trends setting usages; once they proven working in military which they have already in Ukraine… ka Ching!! Recent 2ndary IPO provides runway capital to enable adequate inventory supply support
0 · Reply
billyl
billyl Oct. 24 at 5:48 PM
$HUMA wars and crazy street violences are never going to stop… and seem only increasing… HUMA’s new tech will treat soldiers and trauma patients with faster recovery and less complications - ER will be good to great…!!!
0 · Reply
FatherofTrades
FatherofTrades Oct. 24 at 5:46 PM
$HUMA 2C January 26, 3C Jan 27.
1 · Reply
jmlin1
jmlin1 Oct. 24 at 5:27 PM
$HUMA what is poor thing that can not make a move even in this market.
0 · Reply
Diefreeandsell
Diefreeandsell Oct. 24 at 1:12 PM
$HUMA looks good to me, you?
1 · Reply
Ppbrain
Ppbrain Oct. 24 at 6:54 AM
$HUMA this is how the CEO and her husband sleep every night, knowing they rugged investor hard earn cash...
1 · Reply
Diefreeandsell
Diefreeandsell Oct. 23 at 6:02 PM
$HUMA 50% more please!
0 · Reply
stocktwitsaccount69
stocktwitsaccount69 Oct. 23 at 3:53 PM
$HUMA Nov $2 calls look dirt cheap
0 · Reply
jllpz
jllpz Oct. 23 at 2:08 PM
$HUMA some would miss a good thing even if it bit them on the nose
0 · Reply
Rocketstockz
Rocketstockz Oct. 23 at 1:48 PM
$HUMA company is very quiet i think we are in for a series of positive surprises
1 · Reply
Ppbrain
Ppbrain Oct. 23 at 8:04 AM
$HUMA this place is dead... 🦗..🦗........🦗
2 · Reply
Wolf1971
Wolf1971 Oct. 23 at 12:55 AM
$HUMA cabg is the thing that makes this stratospheric
2 · Reply
Michael_Krombopulos
Michael_Krombopulos Oct. 22 at 4:37 PM
$RR $FUBO $DFLI $HUMA Market trying to get stop losses, force margin calls, force selling, force rebalancing positions which in turn can cause more selling. … then the sun comes out and buying starts, sometimes ferociously. Buy shares with your options, only you can prevent market drops
1 · Reply
Rybod30
Rybod30 Oct. 22 at 3:13 PM
$HUMA https://www.fda.gov/news-events/press-announcements/fda-approves-first-acellular-tissue-engineered-vessel-treat-vascular-trauma-extremities Made for DOD, I realize there are detractors saying it was rushed through the process etc, but it’s successful use on the actual battlefield in Ukraine makes this an obvious play for me. If I was a soldier wherever, would I want this readily available?! Resounding yes…though with all that being said🤷‍♂️😬..
1 · Reply
Rybod30
Rybod30 Oct. 22 at 2:53 PM
$HUMA Order from DOD will show eventually, probably😬😳🤷‍♂️…
4 · Reply
Migane
Migane Oct. 22 at 2:25 PM
$HUMA last comment. Does anyone have the information of any of the main hands playing here??
1 · Reply
Migane
Migane Oct. 22 at 1:53 PM
$HUMA they are actually selling! Is gonna be volatile but its an amazing business
0 · Reply
stockwitsuser2449
stockwitsuser2449 Oct. 22 at 10:46 AM
$RANI well...Here is what my AI assisted thoughts are on this vs. $HUMA Humacyte has more cash than Rani and has a lead product approved (Symvess) — giving it a slightly more advanced status in commercialization than Rani. Rani’s cash situation is more urgent: very low cash, meaningful debt obligations, heavy dilution risk. Their platform has technical promise, but execution and funding risks are very high. Both companies have minimal revenue, large net losses, and significant dilution risk — typical of early stage biotech. In terms of “fundamentals”, Humacyte appears less risky (relatively speaking) because of the approved product and somewhat stronger cash position; but “less risky” here is still very high risk. Rani has higher potential upside if successful, but also markedly higher risk of failure or capital shortfall. Bearish given the technical run up on RANI and bullish on HUMA
0 · Reply
RickyIsRich
RickyIsRich Oct. 22 at 1:47 AM
$HUMA unbiased how will everyone think the earnings will be
3 · Reply
Migane
Migane Oct. 21 at 8:36 PM
$HUMA what about this business. Will it reach 3$ some day? Im new here
1 · Reply